FundedIQ

Funded Health Care Startups in Pittsburgh

Ten funded health care startups tied to Pittsburgh appear in the most recent window shown, with round dates spanning 2021-12-02 (Rimsys, $16M) through 2025…

Ten funded health care startups tied to Pittsburgh appear in the most recent window shown, with round dates spanning 2021-12-02 (Rimsys, $16M) through 2025-04-04 (Elizabeth Seton Center, $10K). Disclosed amounts are highly uneven: PeopleOne Health’s $32M (2024-10-24) sits near the top, but Free Market Health’s $14M (2022-04-19) and Apollo Neuroscience’s $15M (2022-03-17) form the next tier, while KaliVir Immunotherapeutics at $100K (2022-03-16) is a low outlier compared with the rest.

The timing clusters more than the geography: seven of the ten rounds fall between 2022 and 2024, including two back-to-back March 2022 closings (Apollo Neuroscience on 2022-03-17 for $15M and KaliVir Immunotherapeutics on 2022-03-16 for $100K). Stage classification is mixed: four of the ten entries list “Series Unknown” (Elizabeth Seton Center; ThoroughCare; Korion Health; sovaSage), while the remainder spans Seed (Handl Health) and Series A/B across Free Market Health ($14M), Apollo Neuroscience ($15M), Rimsys ($16M), and PeopleOne Health ($32M).

Most recent rounds

10 shown

Related listings

Frequently asked

What’s the largest disclosed round in this Pittsburgh health care set, and how far ahead is it?

PeopleOne Health’s $32M (Series B, 2024-10-24) is the largest disclosed amount in the rows shown, and it stands noticeably above the next-largest disclosed amounts of $16M (Rimsys, 2021-12-02) and $15M (Apollo Neuroscience, 2022-03-17).

Are the round dates clustered, or evenly spread across the window?

The dates cluster around 2022–2024: five of ten rounds fall in 2022–2024, including two consecutive days in mid-March 2022 (KaliVir Immunotherapeutics on 2022-03-16 for $100K and Apollo Neuroscience on 2022-03-17 for $15M).

Which outlier amounts should analysts flag first?

KaliVir Immunotherapeutics at $100K (2022-03-16) is the clearest low outlier versus other disclosed rounds that are mostly in the $1M–$16M range, with the next-lowest disclosed amounts being Korion Health’s $1M (2024-09-06) and Elizabeth Seton Center’s $10K (2025-04-04).

Is Pittsburgh’s representation uniform across sectors and locations, or does anything differ?

All ten entries are labeled Health Care and use the same city context (Pittsburgh, Pennsylvania, United States), with no alternate geography shown. The only marked “difference” within the segment is stage/amount dispersion rather than location (e.g., PeopleOne Health $32M in 2024-10-24 vs. Elizabeth Seton Center $10K in 2025-04-04).

How does the stage mix look when focusing on disclosed rounds with known classifications versus “Series Unknown”?

Four of ten entries are labeled “Series Unknown” (Elizabeth Seton Center on 2025-04-04 for $10K; ThoroughCare on 2024-10-02 for $5M; Korion Health on 2024-09-06 for $1M; sovaSage on 2022-06-24 for $4M). Among known stages, Series A accounts for multiple large checks (Free Market Health $14M on 2022-04-19; Apollo Neuroscience $15M on 2022-03-17; Rimsys $16M on 2021-12-02), while Seed appears for Handl Health ($3M on 2024-04-24) and Series B appears for PeopleOne Health ($32M on 2024-10-24).

Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.